Ignite Creation Date:
2025-12-24 @ 2:28 PM
Ignite Modification Date:
2026-01-29 @ 10:08 AM
Study NCT ID:
NCT05626959
Status:
UNKNOWN
Last Update Posted:
2022-11-25
First Post:
2022-11-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluating the Efficacy of NTI164 in Young People With Autism Spectrum Disorder
Sponsor:
Fenix Innovation Group
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
NTIASD2
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None